AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr | ₹-1,947 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹800 Cr |
Mar2023 | ₹1,814 Cr |
Mar2022 | ₹-2,969 Cr |
Mar2021 | ₹-1,365 Cr |
Mar2020 | ₹-1,947 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹800 Cr | -55.89 | |
Mar2023 | ₹1,814 Cr | Positive | |
Mar2022 | ₹-2,969 Cr | Negative | |
Mar2021 | ₹-1,365 Cr | Negative | |
Mar2020 | ₹-1,947 Cr | - |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,294.4 Cr | 0.1% | 9.5% | 4.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.1% |
9.5% |
4.2% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses